The Company of Biologists is delighted to announce the renewal of our Read & Publish Open Access agreement with the Max Planck Digital Library (MPDL).
The agreement will run from 1 January 2024 until 31 December 2026, and corresponding authors at Max Planck Society’s 86 institutes can continue to publish research articles immediately Open Access (OA) in our hybrid journals (Development, Journal of Cell Science and Journal of Experimental Biology) and our fully Open Access journals (Disease Models & Mechanisms and Biology Open) without paying an article processing charge (APC). Researchers at participating institutions also benefit from unlimited access to our hybrid journals, including their full archives dating back to 1853.
Ádám Dér, Head of the Scientific Information Provision at MPDL, says:
“We at the MPDL are delighted to extend our collaboration with The Company of Biologists, which means we can continue to offer our researchers the possibility to publish open access in all the publisher’s journals as well as access to all previously published content. Providing these opportunities to our authors is at the heart of our overall strategy in the world of scholarly publishing, in line with the Max Planck Society’s vision of openness, which in turn reflects the principles of the OA2020 Initiative and the Berlin Declaration on Open Access.”
Rich Blount, Regional Sales Manager at The Company of Biologists, says:
“We are pleased to be continuing our partnership with the Max Planck Digital Library and to offer authors in 86 Max Planck Society institutes the opportunity to publish Open Access research articles in our five prestigious journals.”
Claire Moulton, Publisher at The Company of Biologists, says:
“As a not-for-profit publisher dedicated to supporting the biological community worldwide, we have a long-standing commitment to Open Access publishing. Our journals were the first in the world to be awarded Transformative Journal status by Plan S and the success of our Read & Publish initiative has already driven a significant increase in Open Access research content in our hybrid journals. We welcome the renewal of our Read & Publish agreement with the Max Planck Digital Library and look forward to working together to promote the growth of Open Access publishing in the biological and biomedical sciences in Germany.”
